Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

So nice to have documented facts about EAPH.

One excellent source of information is the SEC. which determines any Claims of scams, or false and misleading information, etc.

EAPH June 30, 2016 SEC Filing Verifies EAPH has no issues with Securities Exchange Commission Rules and Regulations what-so-ever.

Some have a growing concern and worry they will not be able to purchase EAPH Shares below market value for themselves or their clients very much longer and may not receive their percentage bonus. The chatter intensifies as EAPH's PPS continues to move up. Whatever the EAPH entry point may be it would be hard for one not to make profits IMO.

Easton Pharmaceuticals, Inc.
(A Development Stage Company)
Financial Statements For Quarter Ended June 30, 2016
Prepared By Management Without Audit ________________________________________________________________________________________

List any restrictions on the transfer of security:
None

Describe any trading suspension orders issued by the SEC in the past 12 months.
None

List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
None